Skip to main content
Clinical Trials/ISRCTN91319318
ISRCTN91319318
Completed
N/A

The effect of different cardiovascular risk presentation formats on individuals? intentions, understanding and emotional affect: A Randomised Controlled Trial using a web-based risk formatter

Cardiff University (UK)0 sites800 target enrollmentJanuary 12, 2010

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Cardiff University (UK)
Enrollment
800
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 12, 2010
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Cardiff University (UK)

Eligibility Criteria

Inclusion Criteria

  • Male and females aged between 45 and 64 years, who have not been previously diagnosed with coronary heart disease

Exclusion Criteria

  • 1\. Below the age of 45 or over the age of 64 years
  • 2\. Previous diagnosis of cardiovascular disease
  • 3\. Inability to read English
  • 4\. Inability to access to a computer with the internet
  • 5\. Inadequate IT skills

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 3
ong term impact of RAS inhibition on cardio-renal outcomes: a comparative trial of angiotensin converting enzyme inhibitors, angiotensin receptor blockers or combined therapy with both agents in patients with one or more cardiovascular risk factors and microalbuminuria, diabetic or not diabetic.Patients with one or more cardiovascular risk factors and microalbuminuria, diabetic or not diabetic.Cardiovascular - Normal development and function of the cardiovascular systemMetabolic and Endocrine - Diabetes
ACTRN12607000333415Consorzio Mario Negri Sud2,100
Recruiting
Phase 1
StopstudyTransgender women using long-term gender-affirming hormone therapyTherapeutic area: Psychiatry and Psychology [F] - Psychological Phenomena [F02]Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
CTIS2023-505143-39-00Amsterdam UMC30
Recruiting
Phase 2
Comparison of cardiovascular effects of ropevacaine and lidocaine with epinephrine in implant surgeryHemodynamic effects.
IRCT20211127053190N1Shahid Beheshti University of Medical Sciences18
Active, Not Recruiting
N/A
Efectos Sobre Marcadores de Riesgo Cardiovascular de la Adición de Metformina al Tratamiento con Hormona de Crecimiento en Pacientes Prepuberales con Antecedentes de Peso Bajo al Nacer para la Edad Gestacional y sin Recuperación de Talla Postnatalcambios endocrinometabólicos y de composición corporal en pacientes con bajo peso al nacimiento sin recuperación de peso/ talla en tratamiento con hormona de crecimiento
EUCTR2009-016246-12-ESHOSPITAL SANT JOAN DE DÉ
Recruiting
N/A
Implications of aggressive cardiac risk factor management on the catheter ablation for atrial fibrillatio
ACTRN12613000444785Royal Melbourne Hospital150